Susan Thornton Edwards

Title: Susan Thornton Edwards: Innovator in Neuromodulation Monitoring

Introduction

Susan Thornton Edwards is a prominent inventor based in Santa Rosa, CA (US). She has made significant contributions to the field of neuromodulation, particularly in the monitoring of biomarkers that indicate the efficacy of neuromodulation procedures. Her innovative work has the potential to enhance patient outcomes in renal nerve treatments.

Latest Patents

Susan holds a patent for her invention titled "Monitoring of neuromodulation using biomarkers." This patent encompasses methods, devices, compositions, and kits designed to monitor the efficacy of neuromodulation based on changes in the level or activity of specific target biomarkers. The method involves delivering a catheter to a target renal blood vessel and partially inhibiting sympathetic neural activity of a renal nerve. Following this, the post-neuromodulation levels of biomarkers are determined, which correlate with sympathetic nervous activity in the patient. The success of the renal neuromodulation procedure is assessed by comparing these levels to predetermined benchmarks.

Career Highlights

Susan is currently employed at Medtronic Ireland Manufacturing Unlimited Company, where she continues to develop innovative solutions in the medical technology sector. Her work focuses on advancing techniques that improve patient care through effective neuromodulation strategies.

Collaborations

Throughout her career, Susan has collaborated with notable colleagues, including Ayala Hezi-Yamit and Rudy Beasley. These partnerships have fostered a collaborative environment that encourages innovation and the sharing of ideas.

Conclusion

Susan Thornton Edwards is a trailblazer in the field of neuromodulation, with her patent and work at Medtronic contributing to advancements in medical technology. Her dedication to improving patient outcomes through innovative monitoring techniques is commendable.